Fred Alger Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-152,610
Closed -$314K 563
2022
Q4
$314K Buy
152,610
+17
+0% +$38 ﹤0.01% 421
2022
Q3
$401K Buy
152,593
+35
+0% +$123 ﹤0.01% 406
2022
Q2
$552K Sell
152,558
-3,111
-2% -$15.8K ﹤0.01% 387
2022
Q1
$1.2M Sell
155,669
-939
-0.6% -$10.5K ﹤0.01% 374
2021
Q4
$2.21M Sell
156,608
-5,474
-3% -$80.7K 0.01% 353
2021
Q3
$2.84M Buy
+162,082
New +$2.85M 0.01% 327

Other funds holding SOPH

Fred Alger Management's SOPH Position: Q1 2023 in Review

Fred Alger Management sold out of SOPHiA GENETICS (SOPH) in Q1 2023, closing a stake of 152,610 shares — an estimated $314K sold.

Fred Alger Management first reported a position in SOPH in Q3 2021 and held it in 6 quarters. The position peaked at $2.84M in Q3 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q1 2023.

  • Fred Alger Management reported no remaining SOPHiA GENETICS position as of Q1 2023 after selling out during the quarter.
  • Fred Alger Management sold 152,610 SOPHiA GENETICS shares in Q1 2023, an estimated $314K.
  • Fred Alger Management first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 6 quarters.
  • Fred Alger Management's SOPHiA GENETICS position peaked at $2.84M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2023.

Based on Fred Alger Management's 13F filing for Q1 2023, filed 15 May 2023.